Remove 2016 Remove Finance Remove Human Resources Remove Short-term
article thumbnail

This Pharma Company Stays Innovative by Doing Two Things

Harvard Business Review

Roivant was addressing some sobering realities: In 2016, only 22 new drugs were approved by the U.S. Year-on-year price increases for existing therapies have allowed the industry to maintain profitability, but those short-term fixes have come at a heavy cost: decreased public satisfaction with the industry and increased political scrutiny.

article thumbnail

Inequality Isn’t Just Due to Market Forces — It’s Caused by Decisions the Boss Makes, Too

Harvard Business Review

Companies can be divided into two types , in terms of how they approach hiring and compensation: organizational oriented and market oriented. The shorter-term orientation discourages employers from bearing risks on behalf of their workers and encourages them to use employment practices that lower direct costs and increase flexibility.

article thumbnail

5 Ways U.S. Hospitals Can Respond to Medicare’s Mounting Costs

Harvard Business Review

Intense pressure from the $719 billion Medicare program on the finances of U.S. About three-fourths of short-term acute-care hospitals lost money treating Medicare patients in 2016, according to the Medicare Payment Advisory Commission (MedPAC), an independent agency established to advise the U.S. The losses of U.S.

Cost 8